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tM$ectives. The pwpose of this study was to examine whether 
tumor necrosis factor-alplm (TNF-alpha) is rekased directly f&m 
the isehemic myoeardiom uudergoiag reperhmiou. 
&&grouad. Tumor necrosis factor-alpha is a protein hotmoae 
produced by systemic leukoqtes (primarily by activated macro- 
phages). It has been impliited as a systemic mediator in tbe 
development of septic slmck and other pathlogic couditious. 
SerumTNF-alpbalmsalsobeendetectediaavarietyofcardtac 
disease states aud after q yocardii isckmii~reperfusioa iujmy. 
Metitads. Nine isolated rat bearts uadergoiug 30 mio of perfu- 
siou, followed by warm cardiiplegic arrest, 1 b of global iscbemia 
aad 30 min of reperlimioo, were investigated us@ the modilied 
LaugendoRmodel. 
&&.s. Sigaiftcant amouats of TNF-alpha (752 + 212 pmoU 
Tumor necrosi-. factor-alpha (TNF-alpha), or cachectin, is a 
polypeptide hormone that has a wide range of biological 
activities (1). It is produced by a host in response to stress- 
infection, inflammation, tissue injury and shock-and has 
recently been recogniid as a myocardial depressant substance 
(2). 
This qtokine does not exist in a stored form, but is 
synthesized de novo after cellular activation by a number of 
cells, including monoeyteslmacrophages, lymphocytes, natural 
killer cells, glomerular mesangial cells, astrocytes and micro- 
glial cells of the brain and Kupffer’s cells of the liver (3). 
Circulating TNF-alpha has also been implicated in a variety 
of cardiac disease states, including acute viral myocarditis (4). 
cardiac allograft rejection (5), myocardial infarction (6) con- 
gestive heart failure (7) and after cardiopulmonary bypass 
surgery (8,9). The involvement of TNF-alpha in myocardial 
&hernia-reperfusion injury has recently been demonstrated 
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ml) were deteckd in the e&eat during the first minute of 
reperfusii. Tumor rwrosis factor-alpha levels correlated With 
postiscbfmii detwioiatiou in peak systolic pressures (r = 0.7882, 
p = O.tllZ), dP/dt mas (r = 8.67%. p = W&441. time-pressure 
integral (r = 0.7661, p = O.W6) mod posthcbemC creatiue k&se 
levels (r = @.8367, p = 0.005). Tbe deterioratioa in comaary Row. 
bowewr, was inversely awrelated titfs TNF-alpha levels lr = 
-0.7581, p = 0.018). 
cxwtdhm. To our kmwkdge, this study is the first t? suggest 
tbai tbe isolated rat myocanlium syntbesii aad relertses l%F- 
alpha in respoase to iscbemia aud repels@ which directly 
correlates with tk postisckmic deterioratwa in myocardii 
mecbaaical pehmawe aad the amount of cellubr necmsir 
(.’ Ant cd( Gythb 1996;28:247-52, 
In all previous studies TNF-alpha was detected in periph- 
eral blood samples withdrawn either during laboratcty exper- 
imental studies or directly from patients. ~LXGI systemic 
mechanisms acre thought to be responsible for cytokine 
effects. including circulating leukocytes (11.12). free radbt 
release (13-16) and the increase m gut mucosa permeability to 
gram-negative bacterial endotoxins during cardiopulmonary 
bypass surgery (8,17). fhe possibility that TNF-alpha is direcdy 
released by the ischemic myocardium has never been imesti- 
gated. 
The purpose of this study was to exa;nine whether TNF- 
alpha is released from the isolated heart undergoing prolonged 
cardioplegic ischemia and repertusion in a blood-free environ- 
ment. A modified IangendoA iso!ated rat heart model was 
used. 
Methods 
Male Wistar rats (weight 3x1 2 4.9 g) were anesthetized by 
intraperitoneal injection of pentobarbital sodium (36 mg&g) 
and heparinized. Their hearts were rapidly excised. immersed 
in ice cold h+zGred saline and mounted on the stainless 
steel cannul~ of a mod&d Langendorff perfirsii apparatus. 
Retrograde aortic perfusion was initiated at a perfusii 
pressure of 85 mm Hg with an oxygenated modified Krebs- 
Hem&it buffer solution of the folknving cosnpositicn (in 
mm&liter): Nail 118. Kc1 4.7, CaCl 2.0, MgSO.+ 7Hp 1.2 
KH,pO, 1.2; glucose 11.1 and NaHCO, 25. Tbe perfusate was 
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bubbled continuously with 95% oxygen and 5% carbon diox- 
ide, maintaining a pH of 7.4 to 7.5. Vahtes of PO, and Pro, in 
the perfusion solution were 450 to 5f1, mm Hg and 25 to 
30 mm Hg, respectively. 
provided by Dr. Amarant from Reprogcn Ltd, Rehovot, Israel. 
The limit of detection was 1 U/ml. 
The heart temperature was monitored by a thermistor 
implanted in rhe right ventricular wall and carefully main- 
tained at 37°C or 31°C (at &hernia) by means of water 
jacketing the perfusate reservoir and the isolated heart. The 
right atrium was removed, and the heart was paced to 
300 beats/min at 4 V using an external pacen&er (Devices 
Limited, Implants Division, type E4162). ensuring identical 
heart rates for all hearts. A water-filled latex balloon was 
pIapEd in the left ventricular cavity through a small incision in 
the lefr atrium and was connected to a Mennen Medical PI 
32284 pressure transducer. The balloon was tied and inflated 
to a volume that produced 0 mm Hg diastolic pressure. Zero 
calibration of the pressure transducer was examined through- 
out the experiment. 
Perfusate afferent and efferent gases were measured after 
IS min of stabitiration, 1 min before cardioplegia, after 10 min 
of reperfusion and at the end of reperfusion. Samples were 
withdrawn from the Langcndorlf perfusion apparatus and from 
the right ventricle using a tiny polyethylene catheter inserted 
through a pulmonary artery incision. Oxygen consumption 
(mmolelh per g) was calculated using the following formula 
(23): 
,\rteriovenous 0: tension (mm Hz) 
760 (mm Hg) 
X 
Soluhility of 0: at 37°C (ml/ml ti,O) 
22.4 ~mli~mol) 
Left ventricular peak systolic pressure; time-to-peak systolic 
pressure; relax&,n time; the first derivative of the rise and fall 
in left ventricular pressure (dP/dt max and dP/dt min); the area 
calculated under the left ventricular developed pressure curve 
(pressure-lime integral), which correlates with oxygen con- 
sumption (18); and coronary flow were measured. The various 
variables were continuously recorded, and measurements were 
taken at 1%min intervals. 
Coronary flow (ml/h) x Dryw~~ght ofheart(gj’ 
Finally, the hearts (I .24 + 0.027 g) were dried at 90°C for 
24 h to achieve a constant dry weight (0.2 + 0.048 g). 
Ethics. All anima!s received humane care, as described in 
“Principles of Labora’;ry Anima: Care,” formulated by the 
National Society for Meclra’ Research, and the “Guide for 
the Care and Use of Laboratory Animals,” prepared by the 
National Academy of sC’~ces and published by the National 
In:.irutes of Health (NIH publication no. 80-23, revised 1985). 
Protocol. In nine rats, control measurements were re- 
corded after a 15-min period of stabilization. Thereafter, each 
heart was perfused for 30 minutes. Warm cardioplegia was 
initiated for 2 min (37°C; perfusion pressure 73 mm Hg; KCI 16 
meqilitcrs in Krebs-Henseleit solution), and a 60-min period of 
global &hernia at 31°C was applied to the arrested heart. We 
performed a similar protocol with a 45-min period of &hernia 
previously (19). However, to bring the myocardial pcrformancr 
to extreme deterioration, we decided to lengthen the ischemic 
period to 60 min. 
Statistics. Results are presented as the mean ? SE. The 
TNF-alpha measurements in the coronary etlluent were nor- 
malized to gram of dry heart weight. Pre- and postischemic 
measurements taken at IO-min intervals were subjected to 
analysis of variance (ANOVA) with repeated measures. Sev- 
eral specific data measured at baseline, at the end of perfusion 
and the end of reperfusion were analyzed by the paired 
Student f test. Pearson’s correlation coefficient regression 
analysis was calculated between TNF-alpha levels in the eIRu- 
ent and the percentage of cardiac functional injury measured 
at the end of the repcrfusion period, and also between 
TNF-alpha levels and CK levels. Significance was established 
at the level of p < 0.05. 
Results 
Creatine kinase (CK) activity was measured speclophoto 
mctriially in the effluent during the first minute of reperfusion 
after &hernia (20). Measurements of left ventricular ftinclion 
were taken every 10 min during the 30 min of reperfusion. 
Etierent perfusale fluid samples for TNF-alpha measure- 
ments were withdrawn at baseline measurements (I5 min after 
stabilization), after 30 min of perfusion, immediately after 
ischcmia (first millililer). 10 min of reperfusion and at termi- 
nation of reperfusion (YJ min), and were immediately stored at 
-70°C until the asay on moue L929 cells according :o the 
methods described by Wallach (21) and Y&set al. $2). Each 
a&y included a a\dnjsrd cutve or recombinant human TNF- 
alpha (specific activity 2.5 v IO’ IUlmg protein). kindly 
Hemodynamic changes. Hemodynamic measurements, 
t;lken after 15 min of stabilization (baseline measurements) 
and after a 30-min perfusion period (before &hernia), are 
summarized in Table 1. No statistically significant differences 
of the various hemodynamic and oxygen consumption data 
were noted between tbcse two ii,%.- points. After 1 h of 
cdrdioplcgic ixhemia (duri.ig reperfusion), there was a signif- 
icant decrease in left ventricular peak systolic pressures 
(ANOVA, p = 0.02), dP/dt max and dP/dt min (ANOVA, p = 
iJ.005 and p = 0.03, respectively), the pressure-time integral 
(ANOVA, p = 0.001) ;md coronary flow (ANOVA, p < 
O.tWIol). when compared with preischemic measurclnents (Ta- 
hlc I). Avcraec effluent CK levels detected during the hrst 
minute arc ‘I ‘,rhemia were 73.2 2 5.6 U/liter. 
Tumor aerrj4z factar-alpha &ease. Significant amounts 
of TNF-alpha (752 i 212 pmoliml. 4.33 2 1.13 nmoVm1 x g 
dry lieart weight) w#:rc’ detected in the ctlllrent during the first 
minute of reFrfu\ion. In all other sumples taken during 
banline mdasurcments (after 15 min of stabilization). before 
ischemia (after 10 ;.-: 311 min of perfusion) and after 10 and 
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Table 1. Myocardial Performance 
Before At M mio of 
Baseline Iwhemia Repelfusion 
Peak systo!ic pressure 129 i: 2.1 123.5 + 3.54 64.2 -’ 2.5’ 
(mm W 
dP/dt mat (mm Hgk) 4,042 _+ 390 3$58 _f 383 2,297 zt 295’ 
dP/dt min (mm Hgls) -2,915 2 190 -2851+ 173 -1,502 -t 190’ 
Tii-pressure integral 8.89 2 fJ.35 8.17 T 0.49 4.1Y 2 0.21. 
(mm Hg x s) 
Cornnary flow lY.l + 0.86 17.8 * 0.73 12.3 r 0.56’ 
(mlhin) 
Oxygen consumption 1.5M i: 0.05 1.53 t 0.03 0.9 I -c u.nflt 
(mmobli per g) 
*p c IWKI tp < 0.002. po&chemic (At 30 min of Reperfusion) verw 
baseline measurement% Data are presented as mean value + SE. 
30 min of reperfusion, T’NF-alpha was below detectable levels 
(Table 2). 
Neutralization of TNF-alpha cytotoxic activity. All effluent 
cytotoxic activity was neutralixed by freincubation with anti- 
murine T’NF-alpha monoelonal antibocly: 62.5 ng of antibodies 
completely neutralized I U of effluen TNF (n = 6) whereas 
31.25 ng of antibodies provided 80 5 3% of complete neutral- 
ization (n = 6, p < tI.O02), thus conhrming that the cytotoxic 
activity was due to I’NF-alpha. 
Correlation analysis. Postischemic TNF-alpha levels sig- 
nificantly correlated with the mechanical deterioration of the 
hearts undergoing &hernia (Fig. I) and with postischemia CK 
levels (Fig. 2). The deterioration in coronary flow. however, 
was inversely correlated with TNF-alpha levels (r = -0.7581, 
p = 0.018, Fig. 3). 
Discussion 
blood-free environment), myocardial ischemia-reperfusion m- 
jury (left ventricular dysfunction) and the amount of celiular 
necrosis (CK) were also established. 
Systemic detectton dTNF. The very same cytokine (TNF- 
alpha) that in previous studies was detected in senmr samples 
of rats undergoing myocardial ischemia and reperfuslon (IO), 
or in patients undergoing other stress-induced situations, such 
as septic shock during endotoxemia (U), wasting in cancer (26) 
and a variety of cardiac disease states (4-9), was found here to 
be secreted from the ischemic rep&used myocardmm itself, 
As this cytokine, among others, is produced primarily by 
mononuclear phagocytes upon activation by endotoxhr or 
other microbial products (27) scientists have considered it a 
common systemic mediator of inflammation and endotoxin 
shock (I). Actually, its introduction in 1975 was as an endo- 
toxin-induced serum factor (28). Experimental evidence has 
shown that TNF-alpha is also involved in the pathogenesis of 
bowel (29) hepatic (30) and myocardial ischemia-reperfusion 
injury (3 I). 
Current hypatbeses. Leukocyte infiltration into the myo- 
cardium. indicated by the marked increase in myocardial 
myeloperoxidase activity (IO), is considered to play a pivotal 
role in the phenomenon of myocardial reperfusion injury 
(I IJ2). Increased levels of TNF-alpha were found in the 
peritoneal macrophages collected from rats subjected to myo- 
cardial &hernia-reperfusion injury (IO). TNF-alpha signifi- 
cantly stimulates intracellular adhesion molecule-I expression 
on cardiac myocytes (32). The Entman group has recently 
demonstrated in several experimental studies that intracellular 
adhesion molecule-I plays an important role in neutrophib 
mediated myocardial damage after &hernia and reperfusion 
by promoting adhesive interactions between transmigrated 
neutrophils and cardiac myocytes of the reperfused myocar- 
dium (33-35). 
To our knowledge, this study is the first to suggest that the The current hypothesis is that TNF-alpha is produced by 
isolated reperfujed rat myocardium releases significant systemic leukocytes (primarily by activated macrophages) in 
amounts of TNF-alpha after prolonged iwhemia. We have response to ischemia and reperfusion (lI,l2), which in turn 
shown here that ischemia plays a crucial role in this local causes leukocyte myocardial infiltration (IO) and the release of 
TNF-alpha release from the isolated myocardium, as this leukotrienes (36), thromboxane A, (37), platelet-activating 
cytokine was released only after ixhemia from the isolated factor (38) and cytokines (39). Passive immunization with 
heart mounted for almost 2 h (one of &hernia) on a stainless- specific antibodies against murine TNF-alpha decreased this 
steel cannula of the Langendorlf apparatus. Three hours of de’:terious accumulation of leukocytes in the myocardium and 
isolated heart perfusion under normal conditions, in another reduced the infarct size, CK levels and myocardiril injury (10). 
study, did not cause TNF-alpha cxprewion (24). A direct New insigbts. Our findings of local TNF-alpha syntheses 
correlation bctwecn the local TNF-alpha release (detected in a and release from the ischemic rep&used myocardium can 
Table 2. Tune Course of Tumor Necrosis Factor-Alpha Level, Detected in Eflluenl 
-- 
20 min of Irhercu I min uf IO min of .30 min of 
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shed new light on thcsc hypotheses. Tumor necrosis factor- 
alpha is not only an important substance in the recruitment of 
circulating lcukocftes to sites of inflammatory lesions (40), hut 
is aho prohahly synthesized during i?chemia and released upon 
rcperfusion from the myocardium ttbelf. Furthermore. it pc~s- 
sesse’. L IIUII insult or deleterious effect (myocardial deprcs- 
sion) without tbs. essential “need” for systemic involvement in 
this process. On these grounds, we can better understand the 
importance of TNF-alpha in pathologic pathways during m)o- 
cardial infarction (6). congestive heart f&rc (7). allograft 
rejection (5) and acute vimI myocarditis (4) ‘ ad after catdio- 
pulmonary bypass surgery (X,9,17). 
The secretion of TNF-alpha from cultured cardiac cells 
after exposure IO cndotoxins was previously hinted at only 
circumstantially by replacing the TNF-alpha coding sequence 
and introns with a chloramphenicol acetyltransfcrase coding 
sequence, and hy detecting the biosynthesis of this chloram- 
phcnicol acetyltransfcrasc in cultured cardiac cells after expo- 
sure to cndotoxin, among other tissues (41). In a teccntly 
published in vivo cxperimcntal study Herskowitz et al. (42) 
have shown TNF-alpha messenger RNA expression in the 
postischemic reperfused myocardium. However. to the best of 
our knowledge, the direct rclcasc of TNF-alpha from ~solateJ 
hcarts undergoing global ihchcmia has not yet been dcmnjrr- 
Sttatcd. 
Figure 2. Postirhemic tumor necrosis Iactor-alpha (TNF-n) levels 
correlate with postisch.mic creatine phosphokinase (CPK) Irve!~ (r 7 
0.x307. p = mi)S). 
. 
Figure 1. Correlation ot normalized tumnr ne- 
crosis farrot-alpha (TNF-u) levels in the effluent 
(gram of dry heal: weight) with the deterioration 
(relative to hanline measurements) in peak sys- 
tolic pressltre (r = (1.7882, p = 0.012). dP/dt max 
(r = 0.6795, p .= 0.044) and time-pressure inte- 
gral (r = 0.7MI. p = t1.016) after ischemia, at 
30 min of reperfucion. 
Morcovcr, TNF-alpha release is not an innocent matkcr of 
myocatdial injury. It seems to piay an active role in myocardial 
depression. We have shown in this study the unequivocal 
correlation behvccn local TNF-alpha rclcase and postischemic 
mytrardial injury. Previous experimental and clinical studies 
have also demonstrated the association between depressed 
myocardidl function and elevated levels of TNF-alpha (2,43). 
The TNF-alpha was shown to exert 3 concentration- and 
time-dependent negative inotropic effect that was fully rcvers- 
ihlc when this cytokine was removed (44). Further, treatment 
with neutralizing anti-TNF-alpha aniibody prevented the neg- 
ative inotropic effects of TNF-alpha in isolated myocytes (44). 
A recent study has demonstrated that cardiac myocyte motion 
was depressed when treated with superfusates containing 
TNF-alpha that was released from endotoxin-treated hearts, a 
phenomenon which could he abrogated completely by pre- 
treatment with an anti-TNF-alpha antibodv (24). 
Pnssible mechanisms. A number of &vestigators have 
tried to define mote of the cellular mechanisms responsible for 
this negative inotropic effect. Yokoyama ct al. (44) have shown 
that the negative inotropic effects of TNF-alpha were the direct 
result of alterations in intracellular calcium homeostasis in the 
cardiac myocyte. Treatment with TNF-alpha resulted in de- 
Figure 3. ‘V:e dclerioration in coronary flow after 30 min of reperfu- 
sion. relarlve to baseline coronary flow measurements, inversely cor- 
relates with tumor necrosis factor-alpha (I’NF-a) levels (r = -0.7581, 
p = tLU8). In other words, the more TNF-alpha found in the 
r+schzmic effluent. the more attenuated is the detcrioralion in 
po~ti5ct.cmic coronary flow 
I 
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creased levels of peak intracellular calcium during the systolic 
contraction sequence (44). Another explanation for the myo- 
cardial depresive effect of TNF-alpha, given by Murphy et al, 
(45), was a direct release of free radicals from the myocardial 
endothelium in response to this cytokine. This is a self- 
amplifying process, as production of free radicals was shown to 
further increase TNF-alpha release (46). 
A third explanation for the cytotoxic effect of TNF-alpha on 
the ifchemic heart, recently noted by Finkel et al. (47). 
concerns the nitric oxide pathway. Recent studies report that 
nitric oxide is synthesized in cardiac myocytes (48). endothelial 
cells (49) and vascular smooth muscle ceils (SO) in a pathway 
induced by TNF-alpha. This cytokine-induced nitric oxide 
production might also be responsible for the inverse relation 
between effluent TNF-alpha levels and the coronary flow 
observed in our study. 
Possible sources for myotardiul TNF-alpha secretion. The 
isolated myocardium secretes TNF-alpha after ischcmia- 
reperfusion, provoking speculations regarding its source. Pos- 
sible origins might be cardiomyocytes (41). myocardial endo- 
thelial cells (42) and monocytes or macrophages residing in the 
myocardium. In situ hybridization studies, using highly specific 
biotinylated probes, demonstrated TNF-alpha messsnger 
RNA in cardiac myocytes from endotoxin-stimulated hearts 
(24). Comprehensive answers to this question, however, re- 
quire future investigation. 
Conclusions. Significant amounts of TNF-alpha were de- 
tected in the etfluent of the isolated rat heart undergoing 
cardioplegic arrest and prolonged &hernia. These local TNF- 
alpha levels released from the reperfused heart were directly 
correlated with the postischemic depression in myocardial 
mechanical performance and the amount of mytwardial cellu- 
lar cecrosis. 
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